+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immunodiagnostics Market Size, Share & Trends Analysis Report 2026-2033

  • PDF Icon

    Report

  • 120 Pages
  • September 2026
  • Region: Global
  • Grand View Research
  • ID: 6288513
REQUEST CUSTOMIZATION
Description Jump to:
The global immunodiagnostics market size was valued at USD 30.9 billion in 2025 and is projected to grow from USD 32.5 billion in 2026 to USD 48.1 billion by 2033, at a CAGR of 5.8% from 2026 to 2033. North America dominated the market with the largest revenue share of 37.1% in 2025. Immunodiagnostics represents a major segment of the clinical diagnostics industry and encompasses diagnostic tests that use antigen-antibody reactions to detect or quantify disease-associated biomarkers in patient samples.

Market growth is primarily driven by the rising burden of chronic diseases and the growing adoption of high-sensitivity biomarker-based immunodiagnostic testing. Increasing incidences of cardiovascular diseases, cancer, diabetes, autoimmune disorders, neurological diseases, and other chronic conditions are creating sustained demand for sensitive, specific, and scalable diagnostic assays capable of supporting early disease detection, differential diagnosis, disease monitoring, and treatment selection.

Global Immunodiagnostics Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global immunodiagnostics market report based on product, technology, application, end use, and region:

Product Outlook (Revenue, USD Billion, 2021 - 2033)

  • Reagents & Consumables
  • Instruments
  • Software & Services

Technology Outlook (Revenue, USD Billion, 2021 - 2033)

  • Chemiluminescence Immunoassay
  • Enzyme-Linked Immunosorbent Assay
  • Fluorescence Immunoassay
  • Rapid Immunochromatographic Assay
  • Radioimmunoassay
  • Immunoturbidimetry & Nephelometry
  • Immunoblot Assay
  • Other Technologies

Application Outlook (Revenue, USD Billion, 2021 - 2033)

  • Infectious Disease Testing
  • Oncology Testing
  • Cardiac Testing
  • Endocrinology Testing
  • Autoimmune Disease Testing
  • Allergy Testing
  • Women’s Health & Reproductive Testing
  • Bone, Anemia & Nutritional Testing
  • Therapeutic Drug Monitoring & Toxicology
  • Neurological Testing
  • Other Applications

End Use Outlook (Revenue, USD Billion, 2021 - 2033)

  • Hospitals
  • Laboratories
  • Others

Regional Outlook (Revenue, USD Billion; 2021 - 2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Norway
  • Denmark
  • Sweden
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Technology Segment
1.2.3. Application Segment
1.2.4. End Use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Infectious Disease Testing
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Global Immunodiagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.2.3. Market opportunity analysis
3.3. Global Immunodiagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Global Immunodiagnostics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Immunodiagnostics Market Product Movement Analysis
4.3. Global Immunodiagnostics Market Size & Trend Analysis, Product, 2021 to 2033 (USD Billion)
4.4. Reagents & Consumables
4.4.1. Reagents & Consumables market estimates and forecasts, 2021 - 2033 (USD Billion)
4.5. Instruments
4.5.1. Instruments market estimates and forecasts, 2021 - 2033 (USD Billion)
4.6. Software & Services
4.6.1. Software & Services market estimates and forecasts, 2021 - 2033 (USD Billion)
Chapter 5. Global Immunodiagnostics Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Immunodiagnostics Market Technology Movement Analysis
5.3. Global Immunodiagnostics Market Size & Trend Analysis, Technology, 2021 to 2033 (USD Billion)
5.4. Chemiluminescence Immunoassay
5.4.1. Chemiluminescence Immunoassay market estimates and forecasts, 2021 - 2033 (USD Billion)
5.5. Enzyme-Linked Immunosorbent Assay
5.5.1. Enzyme-Linked Immunosorbent Assay market estimates and forecasts, 2021 - 2033 (USD Billion)
5.6. Fluorescence Immunoassay
5.6.1. Fluorescence Immunoassay market estimates and forecasts, 2021 - 2033 (USD Billion)
5.7. Rapid Immunochromatographic Assay
5.7.1. Rapid Immunochromatographic Assay market estimates and forecasts, 2021 - 2033 (USD Billion)
5.8. Radioimmunoassay
5.8.1. Radioimmunoassay market estimates and forecasts, 2021 - 2033 (USD Billion)
5.9. Immunoturbidimetry & Nephelometry
5.9.1. Immunoturbidimetry & Nephelometry market estimates and forecasts, 2021 - 2033 (USD Billion)
5.10. Immunoblot Assay
5.10.1. Immunoblot Assay market estimates and forecasts, 2021 - 2033 (USD Billion)
5.11. Other Technologies
5.11.1. Other Technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
Chapter 6. Global Immunodiagnostics Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Immunodiagnostics Market Application Movement Analysis
6.2.1. Global Immunodiagnostics Market Size & Trend Analysis, Application, 2021 to 2033 (USD Billion)
6.3. Infectious Disease Testing
6.3.1. Infectious Disease Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
6.4. Oncology Testing
6.4.1. Oncology Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
6.5. Cardiac Testing
6.5.1. Cardiac Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
6.6. Endocrinology Testing
6.6.1. Endocrinology Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
6.7. Autoimmune Disease Testing
6.8. Autoimmune Disease Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
6.9. Allergy Testing
6.10. Allergy Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
6.11. Women’s Health & Reproductive Testing
6.12. Women’s Health & Reproductive Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
6.13. Bone, Anemia & Nutritional Testing
6.13.1. Bone, Anemia & Nutritional Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
6.14. Therapeutic Drug Monitoring & Toxicology
6.14.1. Therapeutic Drug Monitoring & Toxicology market estimates and forecasts, 2021 - 2033 (USD Billion)
6.15. Neurological Testing
6.15.1. Neurological Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
6.16. Other Applications
6.16.1. Other Applications market estimates and forecasts, 2021 - 2033 (USD Billion)
Chapter 7. Global Immunodiagnostics Market: End-use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Immunodiagnostics Market End-use Movement Analysis
7.2.1. Global Immunodiagnostics Market Size & Trend Analysis, End-use, 2021 to 2033 (USD Billion)
7.3. Hospitals & Clinics
7.3.1. Hospitals & Clinics market estimates and forecasts, 2021 - 2033 (USD Billion)
7.4. Diagnostic Laboratories
7.4.1. Diagnostic Laboratories market estimates and forecasts, 2021 - 2033 (USD Billion)
7.5. Blood Banks & Plasma Screening Centers
7.5.1. Blood Banks & Plasma Screening Centers market estimates and forecasts, 2021 - 2033 (USD Billion)
7.6. Home-Care Settings
7.7. Home-Care Settings market estimates and forecasts, 2021 - 2033 (USD Billion)
Chapter 8. Immunodiagnostics Market: Regional Estimates & Trend Analysis
8.1. Regional Dashboard
8.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
8.3. North America
8.3.1. U.S.
8.3.1.1. Key country dynamics
8.3.1.2. Regulatory framework/ reimbursement structure
8.3.1.3. Competitive scenario
8.3.1.4. U.S. market estimates and forecasts, 2021 - 2033 (USD Billion)
8.3.2. Canada
8.3.2.1. Key country dynamics
8.3.2.2. Regulatory framework/ reimbursement structure
8.3.2.3. Competitive scenario
8.3.2.4. Canada market estimates and forecasts, 2021 - 2033 (USD Billion)
8.3.3. Mexico
8.3.3.1. Key country dynamics
8.3.3.2. Regulatory framework/ reimbursement structure
8.3.3.3. Competitive scenario
8.3.3.4. Mexico market estimates and forecasts, 2021 - 2033 (USD Billion)
8.4. Europe
8.4.1. Germany
8.4.1.1. Key country dynamics
8.4.1.2. Regulatory framework/ reimbursement structure
8.4.1.3. Competitive scenario
8.4.1.4. UK market estimates and forecasts, 2021 - 2033 (USD Billion)
8.4.2. UK
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework/ reimbursement structure
8.4.2.3. Competitive scenario
8.4.2.4. Germany market estimates and forecasts, 2021 - 2033 (USD Billion)
8.4.3. France
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework/ reimbursement structure
8.4.3.3. Competitive scenario
8.4.3.4. France market estimates and forecasts, 2021 - 2033 (USD Billion)
8.4.4. Italy
8.4.4.1. Key country dynamics
8.4.4.2. Regulatory framework/ reimbursement structure
8.4.4.3. Competitive scenario
8.4.4.4. Italy market estimates and forecasts, 2021 - 2033 (USD Billion)
8.4.5. Spain
8.4.5.1. Key country dynamics
8.4.5.2. Regulatory framework/ reimbursement structure
8.4.5.3. Competitive scenario
8.4.5.4. Spain market estimates and forecasts, 2021 - 2033 (USD Billion)
8.4.6. Norway
8.4.6.1. Key country dynamics
8.4.6.2. Regulatory framework/ reimbursement structure
8.4.6.3. Competitive scenario
8.4.6.4. Norway market estimates and forecasts, 2021 - 2033 (USD Billion)
8.4.7. Sweden
8.4.7.1. Key country dynamics
8.4.7.2. Regulatory framework/ reimbursement structure
8.4.7.3. Competitive scenario
8.4.7.4. Sweden market estimates and forecasts, 2021 - 2033 (USD Billion)
8.4.8. Denmark
8.4.8.1. Key country dynamics
8.4.8.2. Regulatory framework/ reimbursement structure
8.4.8.3. Competitive scenario
8.4.8.4. Denmark market estimates and forecasts, 2021 - 2033 (USD Billion)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework/ reimbursement structure
8.5.1.3. Competitive scenario
8.5.1.4. Japan market estimates and forecasts, 2021 - 2033 (USD Billion)
8.5.2. China
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework/ reimbursement structure
8.5.2.3. Competitive scenario
8.5.2.4. China market estimates and forecasts, 2021 - 2033 (USD Billion)
8.5.3. India
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework/ reimbursement structure
8.5.3.3. Competitive scenario
8.5.3.4. India market estimates and forecasts, 2021 - 2033 (USD Billion)
8.5.4. Australia
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework/ reimbursement structure
8.5.4.3. Competitive scenario
8.5.4.4. Australia market estimates and forecasts, 2021 - 2033 (USD Billion)
8.5.5. South Korea
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework/ reimbursement structure
8.5.5.3. Competitive scenario
8.5.5.4. South Korea market estimates and forecasts, 2021 - 2033 (USD Billion)
8.5.6. Thailand
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework/ reimbursement structure
8.5.6.3. Competitive scenario
8.5.6.4. Thailand market estimates and forecasts, 2021 - 2033 (USD Billion)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework/ reimbursement structure
8.6.1.3. Competitive scenario
8.6.1.4. Brazil market estimates and forecasts, 2021 - 2033 (USD Billion)
8.6.2. Argentina
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework/ reimbursement structure
8.6.2.3. Competitive scenario
8.6.2.4. Argentina market estimates and forecasts, 2021 - 2033 (USD Billion)
8.7. MEA
8.7.1. South Africa
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework/ reimbursement structure
8.7.1.3. Competitive scenario
8.7.1.4. South Africa market estimates and forecasts, 2021 - 2033 (USD Billion)
8.7.2. Saudi Arabia
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework/ reimbursement structure
8.7.2.3. Competitive scenario
8.7.2.4. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Billion)
8.7.3. UAE
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework/ reimbursement structure
8.7.3.3. Competitive scenario
8.7.3.4. UAE market estimates and forecasts, 2021 - 2033 (USD Billion)
8.7.4. Kuwait
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework/ reimbursement structure
8.7.4.3. Competitive scenario
8.7.4.4. Kuwait market estimates and forecasts, 2021 - 2033 (USD Billion)
Chapter 9. Competitive Landscape
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Share Analysis, 2025
9.4. Company Profiles/Listing
9.4.1. F. Hoffmann-La Roche Ltd.
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Abbott
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Siemens Healthineers
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Beckman Colter, Inc.
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. BIOMÉRIEUX
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. DiaSorin S.p.A.
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. QuidelOrtho Corporation
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Thermo Fisher Scientific Inc.
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Bio-Rad Laboratories, Inc.
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Global Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 4 Global Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 5 Global Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 6 Global Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
Table 7 North America Immunodiagnostics Market, region, 2021 - 2033 (USD Billion)
Table 8 North America Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 9 North America Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 10 North America Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 11 North America Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
Table 12 U.S. Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 13 U.S. Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 14 U.S. Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 15 U.S. Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
Table 16 Canada Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 17 Canada Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 18 Canada Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 19 Canada Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
Table 20 Mexico Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 21 Mexico Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 22 Mexico Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 23 Mexico Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
Table 24 Europe Immunodiagnostics Market, region, 2021 - 2033 (USD Billion)
Table 25 Europe Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 26 Europe Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 27 Europe Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 28 Europe Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
Table 29 UK Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 30 UK Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 31 UK Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 32 UK Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
Table 33 Germany Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 34 Germany Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 35 Germany Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 36 Germany Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
Table 37 France Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 38 France Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 39 France Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 40 France Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
Table 41 Italy Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 42 Italy Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 43 Italy Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 44 Italy Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
Table 45 Spain Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 46 Spain Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 47 Spain Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 48 Spain Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
Table 49 Denmark Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 50 Denmark Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 51 Denmark Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 52 Denmark Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
Table 53 Sweden Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 54 Sweden Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 55 Sweden Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 56 Sweden Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
Table 57 Norway Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 58 Norway Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 59 Norway Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 60 Norway Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
Table 61 Asia Pacific Immunodiagnostics Market, region, 2021 - 2033 (USD Billion)
Table 62 Asia Pacific Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 63 Asia Pacific Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 64 Asia Pacific Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 65 Asia Pacific Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
Table 66 Japan Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 67 Japan Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 68 Japan Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 69 Japan Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
Table 70 China Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 71 China Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 72 China Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 73 China Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
Table 74 India Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 75 India Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 76 India Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 77 India Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
Table 78 Australia Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 79 Australia Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 80 Australia Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 81 Australia Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
Table 82 South Korea Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 83 South Korea Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 84 South Korea Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 85 South Korea Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
Table 86 Thailand Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 87 Thailand Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 88 Thailand Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 89 Thailand Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
Table 90 Latin America Immunodiagnostics Market, region, 2021 - 2033 (USD Billion)
Table 91 Latin America Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 92 Latin America Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 93 Latin America Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 94 Latin America Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
Table 95 Brazil Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 96 Brazil Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 97 Brazil Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 98 Brazil Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
Table 99 Argentina Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 100 Argentina Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 101 Argentina Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 102 Argentina Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
Table 103 MEA Immunodiagnostics Market, region, 2021 - 2033 (USD Billion)
Table 104 MEA Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 105 MEA Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 106 MEA Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 107 MEA Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
Table 108 South Africa Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 109 South Africa Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 110 South Africa Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
Table 111 Saudi Arabia Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 112 Saudi Arabia Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 113 South Africa Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 114 Saudi Arabia Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
Table 115 UAE Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 116 UAE Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 117 UAE Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 118 Kuwait Immunodiagnostics Market, Product, 2021 - 2033 (USD Billion)
Table 119 Kuwait Immunodiagnostics Market, Technology, 2021 - 2033 (USD Billion)
Table 120 Kuwait Immunodiagnostics Market, Application, 2021 - 2033 (USD Billion)
Table 121 Kuwait Immunodiagnostics Market, End Use, 2021 - 2033 (USD Billion)
List of Figures
Fig. 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modelling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Immunodiagnostics Market: Market outlook
Figure 9 Immunodiagnostics Market: Competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Penetration and growth prospect mapping
Figure 13 Industry value chain analysis
Figure 14 Immunodiagnostics market driver impact
Figure 15 Immunodiagnostics market restraint impact
Figure 16 Immunodiagnostics market strategic initiatives analysis
Figure 17 Immunodiagnostics market: Product movement analysis
Figure 18 Immunodiagnostics market: Product outlook and key takeaways
Figure 19 Instruments & systems market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 20 Reagents & consumables market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 21 Software & Services market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 22 Immunodiagnostics market: Technology movement analysis
Figure 23 Immunodiagnostics market: Technology outlook and key takeaways
Figure 24 Chemiluminescence Immunoassay market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 25 Enzyme-Linked Immunosorbent Assay market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 26 Fluorescence Immunoassay market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 27 Rapid Immunochromatographic Assay market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 28 Radioimmunoassay market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 29 Immunoturbidimetry & Nephelometry market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 30 Immunoblot Assay market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 31 Other Technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 32 Immunodiagnostics market: Application movement analysis
Figure 33 Immunodiagnostics market: Application outlook and key takeaways
Figure 34 Infectious Disease Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 35 Oncology Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 36 Cardiac Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 37 Endocrinology Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 38 Autoimmune Disease Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 39 Allergy Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 40 Women’s Health & Reproductive Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 41 Bone, Anemia & Nutritional Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 42 Therapeutic Drug Monitoring & Toxicology market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 43 Neurological Testing market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 44 Other Applications market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 45 Immunodiagnostics market: End use movement analysis
Figure 46 Immunodiagnostics market: End use outlook and key takeaways
Figure 47 Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 48 Hospitals & diagnostic labs market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 49 Pharma & biotech companies market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 50 Home-Care Settings market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 51 market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 52 Global Immunodiagnostics market: Regional movement analysis
Figure 53 Global Immunodiagnostics market: Regional outlook and key takeaways
Figure 54 North America market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 55 U.S. market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 56 Canada market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 57 Mexico market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 58 Europe market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 59 UK market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 60 Germany market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 61 France market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 62 Italy market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 63 Spain market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 64 Sweden market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 65 Norway market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 66 Denmark market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 67 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 68 Japan market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 69 China market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 70 India market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 71 Australia market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 72 Thailand market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 73 South Korea market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 74 Latin America market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 75 Brazil market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 76 Argentina market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 77 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 78 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 79 South Africa market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 80 UAE market estimates and forecasts, 2021 - 2033 (USD Billion)
Figure 81 Kuwait market estimates and forecasts, 2021 - 2033 (USD Billion)

Companies Mentioned

  • F. Hoffmann-La Roche Ltd.
  • Abbott
  • Siemens Healthineers
  • Beckman Colter, Inc.
  • BIOMÉRIEUX
  • DiaSorin S.p.A.
  • QuidelOrtho Corporation
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Related Topics

Related Reports

Immunodiagnostics Global Market Opportunities and Strategies to 2033 - Product Image

Immunodiagnostics Global Market Opportunities and Strategies to 2033

  • Report
  • 296 Pages
  • Global
From
HPV Testing and Pap Test Market Size, Share & Trends Analysis Report by Type (Pap Test, HPV Test), Application (Cervical Cancer, Vaginal Cancer), Product, Technology, End Use and Region with Growth Forecasts, 2025-2033 - Product Image

HPV Testing and Pap Test Market Size, Share & Trends Analysis Report by Type (Pap Test, HPV Test), Application (Cervical Cancer, Vaginal Cancer), Product, Technology, End Use and Region with Growth Forecasts, 2025-2033

  • Report
  • 120 Pages
  • Global
From
Middle East Diagnostic Reagents for Infectious Diseases Market Size, Share & Trends Analysis Report by Product (Molecular Reagents, Immunoassay Reagents), Disease Area, Technology, End Use, Country with Growth Forecasts, 2025-2033 - Product Image

Middle East Diagnostic Reagents for Infectious Diseases Market Size, Share & Trends Analysis Report by Product (Molecular Reagents, Immunoassay Reagents), Disease Area, Technology, End Use, Country with Growth Forecasts, 2025-2033

  • Report
  • 150 Pages
  • Middle East
From
Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Opportunities and Strategies to 2033 - Product Image

Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Opportunities and Strategies to 2033

  • Report
  • 293 Pages
  • Global
From
North America Immunodiagnostics Market Forecast to 2030 - Regional Analysis - by Product, By Clinical Indication, and End User - Product Image

North America Immunodiagnostics Market Forecast to 2030 - Regional Analysis - by Product, By Clinical Indication, and End User

  • Report
  • 200 Pages
  • North America
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.